[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346466-105":59,"doc-detail-346466-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chd4-epigenetically-coordinates-genomic-instability-and-immunosuppression-to-drive-pan-cancer-progression-and-confer-hdac-inhibitor-sensitivity","CHD4 epigenetically coordinates genomic instability and immunosuppression to drive pan-cancer progression and confer HDAC inhibitor sensitivity","","Chromodomain Helicase DNA-Binding Protein 4 (CHD4) is a core ATPase subunit of the NuRD complex and a key epigenetic regulator, yet a systematic pan-cancer view linking its functions to genomic stability and tumor immune microenvironment remains incomplete. An integrated multi-omics analysis using TCGA and complementary databases profiled CHD4 expression, genomic alterations, and clinical associations, correlating CHD4 with genomic instability markers, immune infiltration, and therapy response. Functional enrichment and pharmacogenomics were supported by osteosarcoma in vitro validation, identifying elevated CHD4 as a marker of immune suppression and HDAC inhibitor sensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chd4-epigenetically-coordinates-genomic-instability-and-immunosuppression-to-drive-pan-cancer-progression-and-confer-hdac-inhibitor-sensitivity/346466/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chd4-epigenetically-coordinates-genomic-instability-and-immunosuppression-to-drive-pan-cancer-progression-and-confer-hdac-inhibitor-sensitivity/346466.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CHD4 play in epigenetic regulation?","Question",{"text":112,"@type":113},"CHD4 is described as the core ATPase subunit of the NuRD complex and an important epigenetic regulator.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is CHD4 linked to genomic instability and the tumor immune microenvironment?",{"text":117,"@type":113},"High CHD4 expression correlates with markers of genomic instability (e.g., HRD and LOH) and with an immunosuppressive tumor microenvironment characterized by reduced CD8+ T cell infiltration and increased immune checkpoint molecule expression.",{"name":119,"@type":110,"acceptedAnswer":120},"Why might CHD4 be useful for predicting response to HDAC inhibitors?",{"text":121,"@type":113},"Tumors with high CHD4 expression showed increased sensitivity to HDAC inhibitors such as vorinostat and panobinostat, suggesting CHD4 could serve as a predictive biomarker.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346466,1790404741,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Clinical and Experimental Medicine (2026) 26:150  \n[https://doi.org/10.1007/s10238-026-02081-y](https://doi.org/10.1007/s10238-026-02081-y)  \nRESEARCH  \nCHD4 epigenetically coordinates genomic instability and immunosuppression to drive pan-cancer progression and confer HDAC inhibitor sensitivity  \nGuangxu Fu1,2,3,4,5 · Yong Tao1,2,3 · Keyi Feng1,2,3 · Yuxing Chen1,2,3 · Wen Zhang1,2,3 · Zhen Zhang4,5 · Guoda Hu4,5 · Yunsheng Ou1,2,3  \nReceived: 14 December 2025 / Accepted: 27 January 2026 © The Author(s) 2026  \nAbstract  \nChromodomain Helicase DNA-Binding Protein 4 (CHD4), the core ATPase subunit of the nucleosome remodeling and deacetylation (NuRD) complex, is a key epigenetic regulator. However, a systematic pan-cancer perspective on its functions, particularly its coordinated regulation of genomic stability alongside the tumor immune microenvironment, remains lacking. This study performed an integrated multi-omics analysis using data from The Cancer Genome Atlas (TCGA) and complementary genomic databases. This included systematic profiling of CHD4 expression, genomic alterations, and clinical associations across cancers. We investigated its correlations with markers of genomic instability, immune cell infiltration, and therapy response. Functional enrichment and pharmacogenomic analyses were conducted, supported by in vitro validation in osteosarcoma models. CHD4 was frequently upregulated across multiple cancer types, and its elevated expression was associated with poorer patient prognosis in several malignancies. Pan-cancer analysis revealed that high CHD4 expression correlated significantly with markers of genomic instability, such as homologous recombination deficiency (HRD) and loss of heterozygosity (LOH), and concurrently with an immunosuppressive tumor microenvironment—characterized by reduced CD8 + T cell infiltration and elevated expression of immune checkpoint molecules. Mechanistically, CHD4 expression was closely linked to core components of the NuRD complex, including HDAC1 and HDAC2, suggesting its involvement in chromatin compaction and transcriptional regulation associated with these phenotypes. Furthermore, tumors exhibiting high CHD4 expression showed increased sensitivity to histone deacetylase (HDAC) inhibitors, including vorinostat and panobinostat. This study establishes CHD4 as a pan-cancer epigenetic regulator whose expression is linked to both genomic instability and immune suppression. Furthermore, CHD4 shows promise as a predictive biomarker for sensitivity to HDAC inhibitors, highlighting its potential as a biomarker for guiding epigenetics-based therapeutic strategies.  \nKeywords CHD4 · Pan-cancer analysis · Genomic instability · Tumor immune microenvironment · HDAC inhibitor · Epigenetic therapy · Precision medicine  \n􀀍  \n􀀍  \n1  \n2  \nGuoda Hu  \n[huguoda0011@163.com](huguoda0011@163.com)  \nYunsheng Ou  \n[ouyunsheng2001@163.com](ouyunsheng2001@163.com)  \nDepartment of Orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing 400016, China  \nChongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Yuzhong, Chongqing 400016, China  \n3 Orthopaedic Research Laboratory of Chongqing Medical University, Yuzhong, Chongqing 400016, China  \n4 Department of Orthopedic Surgery, Enshi Tujia and Miao Autonomous Prefecture, The People’s Hospital of Lichuan City, Lichuan, Hubei Province 445400, China  \n5 Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Enshi Tujia and Miao Autonomous Prefecture, Hubei 445000, China  \n1 3  \nIntroduction  \nCancer remains a major global public health threat and the second leading cause of mortality worldwide. According to 2022 global cancer statistics, malignant neoplasms account for approximately 10 million annual deaths, with the disease burden continuing to rise [1, 2] . Despite considerable advances in cancer treatment—particularly the introd","cbCaij7vn6Bi5ezn","https://ap.wps.com/l/cbCaij7vn6Bi5ezn","pdf",4476714,18,"English","# Abstract\n# Keywords\n# Introduction\n## Cancer as a global health threat\n## Epigenetic regulation and tumor microenvironment\n## NuRD complex and CHD4 in cancer","[{\"question\":\"What role does CHD4 play in epigenetic regulation?\",\"answer\":\"CHD4 is described as the core ATPase subunit of the NuRD complex and an important epigenetic regulator.\"},{\"question\":\"How is CHD4 linked to genomic instability and the tumor immune microenvironment?\",\"answer\":\"High CHD4 expression correlates with markers of genomic instability (e.g., HRD and LOH) and with an immunosuppressive tumor microenvironment characterized by reduced CD8+ T cell infiltration and increased immune checkpoint molecule expression.\"},{\"question\":\"Why might CHD4 be useful for predicting response to HDAC inhibitors?\",\"answer\":\"Tumors with high CHD4 expression showed increased sensitivity to HDAC inhibitors such as vorinostat and panobinostat, suggesting CHD4 could serve as a predictive biomarker.\"}]","CHD4 epigenetically coordinates genomic instability and immunosuppression to drive pan-cancer progression and confer HDAC inhibitor sensitivity | PDF",1790061557,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75f8d0315acc8495790017abf899e5e1.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10f2092709816c601ed80844560e17a9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dbc9119c1d0f5553f82e978242ca704.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7daa61e66ccc464b517a7818cf6eac67.webp",980,1301]